Table 1 Characteristics of guidance documents presented by geographical area
Guidance document | Development body | Publication date of current version | Country and language if other than English | CPG | SG | CP | CS | Rigour of development (AGREEII) % | Healthcare system |
|---|---|---|---|---|---|---|---|---|---|
Continental Europe | |||||||||
Epithelial ovarian carcinoma | Dutch Society for Obstetrics and Gynaecology (NVOG) | 2018 | Netherlands (Dutch) | ♦ | 66 | National/Social Health Insurance | |||
Guideline on diagnostics, therapy and follow-up of malignant ovarian tumours | The Association of Scientific Medical Societies in Germany (AWMF), led by German Society for Gynaecology and Obstetrics (DGGG) | 2017 | Germany (German) | ♦ | 81 | National/Social Health Insurance | |||
United Kingdom and Republic of Ireland | |||||||||
Epithelial ovarian / fallopian tube / primary peritoneal cancer guidelines: recommendations for practice | British Gynaecological Cancer Society | 2017 | UK | ♦ | 48 | National Health Service | |||
Ovarian cancer GP referral for symptomatic women | National Cancer Control Programme | 2016 | Republic of Ireland | ♦ | 7 | National/Social Health Insurance | |||
Suspected cancer: recognition and referral | National Institute for Health and Care Excellence (NICE) | 2015 | England, Wales, Northern Ireland | ♦ | 96 | National Health Service | |||
Scottish referral guidelines for suspected cancer | Healthcare Improvement Scotland | 2014 | Scotland | ♦ | 55 | National Health Service | |||
Management of epithelial ovarian cancer | Scottish Intercollegiate Guidelines Network (Part of Healthcare Improvement Scotland) | 2013 | Scotland | ♦ | 76 | National Health Service | |||
Scandinavia | |||||||||
Integrated ovarian cancer patient pathway | The Danish National Health Authority | 2016 | Denmark (Danish) | ♦ | 29 | National Health Service | |||
Ovarian cancer patient pathway | The Norwegian Directorate of Health | 2016 | Norway (Norwegian) | ♦ | 38 | National Health Service | |||
Standardised ovarian cancer care pathway a | Regional Cancer Centre Co-operative Sweden | 2015 | Sweden (Swedish) | ♦ | 55 | National Health Service | |||
Australasia | |||||||||
Assessment of symptoms that may be ovarian cancer: a guide for general practitionersb | Cancer Australia | 2015 | Australia | ♦ | 50 | National/Social Health Insurance | |||
Appropriate referral of women with suspected ovarian cancerb | Cancer Australia | 2015 | Australia | ♦ | 50 | National/Social Health Insurance | |||
Optimal care pathway for women with ovarian cancer | Cancer Council Victoria | 2015 | Australia | ♦ | 10 | National/Social Health Insurance | |||
Suspected cancer in primary care: Guidelines for investigation, referral and reducing ethnic disparity | New Zealand Guidelines Group | 2009 | New Zealand | ♦ | 56 | National/Social Health Insurance | |||
North America | |||||||||
Ovarian cancer: including fallopian tube cancer and primary peritoneal cancer | National Comprehensive Cancer Network | 2018 (v2) | USA | ♦ | 65 | Private Health System | |||
The role of the obstetrician-gynaecologist in the early detection of epithelial ovarian cancer in women at average risk | American College of Obstetrician Gynaecologists and the Society of Gynaecological Oncology | 2017 | USA | ♦ | 11 | Private Health System | |||
Ovarian cancer diagnosis pathway map | Cancer Care Ontario | 2016 | Ontario, Canada | ♦ | 19 | National/Social Health Insurance | |||
Genital tract cancers in females: ovarian, fallopian tube, and primary peritoneal cancers | Guidelines and Protocol Advisory Committee (Medical Services Commission) | 2014 | British Columbia, Canada | ♦ | 16 | National/Social Health Insurance | |||